Cullinan Therapeutics, Inc. (CGEM) Retained Earnings (Accumulated Deficit) USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Cullinan Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2019 to 2024.
  • Cullinan Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$238 M, a 125% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$238 M -$132 M -125% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$201 M -$153 M -321% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 -$177 M -$156 M -747% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$138 M -$142 M -3643% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$106 M +$65.4 M +38.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$47.7 M +$111 M +70% Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$20.9 M +$105 M +83.5% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $3.89 M +$113 M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 -$171 M -$77.6 M -83.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$159 M -$65.6 M -70.2% Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$126 M -$61.4 M -94.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 -$109 M -$53.9 M -97.8% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 -$93.4 M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 -$93.3 M -$51.8 M -125% Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$65 M Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$55.1 M Jun 30, 2020 10-Q 2021-08-10
Q4 2019 -$41.5 M Dec 31, 2019 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.